Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Recruiting 6Active not recruiting 5Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peripheral Nervous System Diseases 1HER2 IHC3+ Advanced Colorectal Cancer 1

Interventions

Specimen Handling 60Magnetic Resonance Spectroscopy 41Carboplatin 32Gemcitabine 29Cyclophosphamide 29Cisplatin 25Biopsy 25Bevacizumab 24pembrolizumab 23Radiotherapy 22Paclitaxel 22Standard of Care 21Injections 21Drug Therapy 21Capecitabine 21fludarabine 20Oxaliplatin 20venetoclax 19Nivolumab 18toripalimab 17Interviews as Topic 17Dexamethasone 16Blood Specimen Collection 16tislelizumab 14Radiosurgery 14cemiplimab 13anlotinib 13Azacitidine 13Pemetrexed 12Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Tablets × 90 days × Clear all
NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Tanta University

Phase 2/3 Not yet recruiting
46 enrolled

Peripheral Nervous System Diseases

NCT07483684 2026-03-19

A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3 Not yet recruiting
142 enrolled
Gastrointestinal

HER2 IHC3+ Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡